clinical and experimental data indicate that the concentration of gastrin-i and somatostatin binding sites in human and rat gastric and duodenal mucosa may be changed in several pathologic conditions , including human peptic ulcer and cancer diseases .
C0030660
pathologic conditions
C0012634
diseases